Excessive Sales Competition and Declining Supply Prices
First written in FY2016. 5 of 10 entries say "Restated". Latest entry: FY2026.
Vital Ksk Holdings moved to the "Worse" side of this theme in 2025.
0 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「Although there were negative impacts from factors including the effects of drug price revisions and sales declines caused by competitive bidding in limited segments of local areas,」
It states that localized sales declines caused by competitive bidding actually occurred in the pharmaceutical wholesale business during the consolidated fiscal year. - FY2026-H1MaterialisedAnnual report
「In the pharmaceutical wholesale business, although there were negative impacts from factors including the effects of drug price revisions and sales declines caused by competitive bidding at certain facilities in limited local areas,」
It states that sales declines caused by competitive bidding actually occurred at facilities and other locations in limited areas, reflecting the previously identified price competition risk. - FY2022RestatedAnnual report
「The Group will continue efforts to maintain deliveries at appropriate prices in accordance with the Guidelines for Improving Distribution.」
It continues to address the risk of lower delivery prices from excessive price competition by maintaining appropriate prices in accordance with the Distribution Improvement Guidelines. - FY2021MaterialisedAnnual report
「In addition, gross profit declined substantially due in part to the impact of price competition with other companies in the same industry. Although we worked to contain selling, general and administrative expenses, including by reducing personnel expenses, we were ultimately forced to report an operating loss.」
It states that the previously excessive price competition risk materialized as a substantial decline in gross profit and an operating loss in the pharmaceutical wholesale business. - FY2021-Q3MaterialisedAnnual report
「In addition to the impact of price reductions from the October 2019 and April 2020 drug price revisions and price competition with industry peers, sales declined substantially.」
It states that price competition with industry peers contributed to a substantial decline in sales and that the previously identified risk from price competition has materialized as an impact on results. - FY2020RestatedAnnual report
「We will continue our efforts to maintain deliveries at appropriate prices in accordance with the Distribution Improvement Guidelines.」
It continues to address the risk of lower delivery prices from excessive price competition by maintaining appropriate prices in accordance with the Distribution Improvement Guidelines. - FY2019RestatedAnnual report
「If excessive price competition arises, market prices will decline, and the Company may have no choice but to respond on price. If it cannot respond on price, the number of products sold may decline.」
It reiterates the risk of lower market prices and a reduction in the number of products sold due to excessive sales competition. - FY2018RestatedAnnual report
「If excessive price competition arises, market prices will decline, and the Company may have no choice but to respond on price. If it cannot respond on price, the number of products sold may decline.」
It reiterates the possibility of lower market prices and a reduction in the number of products sold due to excessive sales competition. - FY2017RestatedAnnual report
「Excessive price competition may arise due to competitors' regional strategies and other factors. If excessive price competition arises, market prices will decline, and the Company may have no choice but to respond on price.」
It reiterates the possibility of excessive sales competition and lower delivery prices as a risk. - FY2016First statedAnnual report
「Excessive price competition may arise due to competitors' regional strategies and other factors. If excessive price competition arises, market prices will decline, and the Company may have no choice but to respond on price.」
It indicates that intensifying competition could result in pricing responses and a reduction in the number of products sold.